Found 26 results in Building Products

This article explores the benefits of a more integrated approach in which the chemistry, manufacturing, and controls (CMC) teams and clinical teams work together at an early stage to achieve greater success for both the development program and patients.

While the first autologous cell therapy commercial products have shown tremendous clinical success, scaling out these therapies while considering individual patient processes is a new challenge.

This ebook discusses efficiencies specific to early biopharmaceutical formulation development and biomanufacturing continuous processing.

How can a patient-centric outlook help scientists tackle the key challenges of early drug development.

Utilize an all-encompassing approach to enable an effective dosage form faster to market.

Summary: Three early drug development experts present insights and techniques to help your clients get their molecules from preclinical to Phase 1 studies.